Minerva Neurosciences, Inc. is a biopharmaceutical company based in Waltham, MA, focused on developing innovative therapies for central nervous system disorders. The company specializes in addressing unmet medical needs in the fields of psychiatry and neurology, with a particular emphasis on conditions such as schizophrenia and insomnia. Through its advanced research and development efforts, Minerva aims to enhance treatment options and improve the quality of life for patients suffering from these challenging disorders.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

10 Patents

#130 in Waltham, MA

#1,773 in Massachusetts

#29,882 in US

#56,092 in the World

Waltham, MA, United States of America

Minerva Neurosciences, Inc.

Forward Citations = 24

9 inventors:

Remy Henri Luthringer (10 out of 10 patents)

Nadine Noel (7 out of 7 patents)

Sandra Werner (6 out of 7 patents)

4. Jay Saoud (4 out of 4 patents)

5. Emmanuelle Georgi (2 out of 2 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Minerva Neurosciences, Inc.. Retrieved from https://idiyas.com/company/minerva-neurosciences

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

9 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]